Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature (609)
British Journal of Cancer (233)
Nature Communications (134)
Pediatric Research (117)
Nature Genetics (108)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (1956)
Reviews (170)
Correspondence (43)
News & Views (27)
Books & Arts (21)
Amendments and Corrections (15)
Comments & Opinion (11)
News (4)
Protocols (2)
Research Highlights (2)
Editorial (1)
Special Features (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biological techniques
Biomarkers
Biotechnology
Cancer
Cell biology
Computational biology and bioinformatics
Diseases
Drug discovery
Genetics
Health care
Immunology
Medical research
Microbiology
Molecular biology
Neuroscience
Oncology
Pathogenesis
Physiology
Risk factors

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–50 of 2253 results

Advanced filters: Author: R. J. Epstein Clear advanced filters

Epstein Barr virus antibody and cancer risk in two prospective cohorts in Southern China

Epstein-Barr virus is associated with increased cancer risk. Here, the authors analysed two population-based prospective cohorts in Southern China to examine the association between increased seropositivity and the risk of multiple cancer types.

Ming-Fang Ji
Yong-Qiao He
Wei-Hua Jia
ResearchOpen Access01 Jul 2025
Nature Communications

Volume: 16, P: 1-12
T and B cell responses against Epstein–Barr virus in primary sclerosing cholangitis

Interrogation of electronic health records and the B and T cell repertoires of people with PSC shows a link between Epstein–Barr virus and primary sclerosing cholangitis, an incurable autoimmune liver disease.

Hesham ElAbd
Mitchell Pesesky
Andre Franke
ResearchOpen Access11 Jun 2025
Nature Medicine

Volume: 31, P: 2306-2316
DNA sequence and expression of the B95-8 Epstein—Barr virus genome

R. Baer
A. T. Bankier
B. G. Barrell
Research19 Jul 1984
Nature

Volume: 310, P: 207-211
fgr proto-oncogene mRNA induced in B lymphocytes by Epstein–Barr virus infection

Marc S. C. Cheah
Timothy J. Ley
Keith C. Robbins
Research16 Jan 1986
Nature

Volume: 319, P: 238-240
A new tumour-derived transforming strain of Epstein–Barr virus

P. A. PIZZO
I. T. MAGRATH
P. GERBER
Research13 Apr 1978
Nature

Volume: 272, P: 629-631
Effect of chloroquine on Epstein–Barr virus expression (reply)

DAVID F. HORROBIN
R. A. KARMALI
Research13 Dec 1979
Nature

Volume: 282, P: 758
Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants

D. J. Moss
I. S. Misko
T. B. Sculley
Research25 Feb 1988
Nature

Volume: 331, P: 719-721
Herpes-like Epstein–Barr Virus in Leprosy

P. S. PAPAGEORGIOU
C. SOROKIN
P. R. GLADE
Research07 May 1971
Nature

Volume: 231, P: 47-49
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy

Nasopharyngeal carcinoma (NPC) lacks effective diagnostic and therapeutic strategies, in particular at advanced stages. Here, the authors show that expression of the somatostatin receptor 2 is induced by Epstein-Barr virus in NPC and has a key role in the diagnosis, imaging, targeted therapies and prognosis of NPC.

Matt Lechner
Volker H. Schartinger
Valerie J. Lund
ResearchOpen Access05 Jan 2021
Nature Communications

Volume: 12, P: 1-11
Chloroquine enhances Epstein–Barr virus expression

R. A. KARMALI
D. F. HORROBIN
J. MUSTO
Research01 Oct 1978
Nature

Volume: 275, P: 444-445
Epstein-Barr virus-driven B cell lymphoma mediated by a direct LMP1-TRAF6 complex

Epstein-Barr virus causes lymphoma. Here the authors describe a direct complex of the viral oncoprotein LMP1 with the cellular TRAF6 protein as a critical virus-host interface for lymphoma survival and validate this complex as a potential therapeutic target.

Fabian Giehler
Michael S. Ostertag
Arnd Kieser
ResearchOpen Access10 Jan 2024
Nature Communications

Volume: 15, P: 1-18
Antigen specificity of clonally enriched CD8⁺ T cells in multiple sclerosis

Sabatino and colleagues examine expanded CD8⁺ T cell clonotypes from a small cohort of multiple sclerosis patients. They identified several cognate peptide epitopes that derive from Epstein–Barr virus, suggesting EBV reactivation may drive pathogenesis in these patients.

Fumie Hayashi
Kristen Mittl
Joseph J. Sabatino Jr
ResearchOpen Access05 Feb 2026
Nature Immunology

P: 1-13
Ephrin receptor A2 is a functional entry receptor for Epstein–Barr virus

The receptor tyrosine kinase EphA2 is identified as an EBV entry and fusion receptor in epithelial cells. EphA2 depletion or absence, or the use of anti-EphA2 antibodies, precludes infection of epithelial cell lines and oropharyngeal carcinoma cells.

Jia Chen
Karthik Sathiyamoorthy
Richard Longnecker
Research01 Jan 2018
Nature Microbiology

Volume: 3, P: 172-180
Transcribed B lymphocyte genes and multiple sclerosis risk genes are underrepresented in Epstein–Barr Virus hypomethylated regions

Lawrence T. C. Ong
Grant P. Parnell
David R. Booth
ResearchOpen Access16 Oct 2019
Genes & Immunity

Volume: 21, P: 91-99
Population-scale sequencing resolves determinants of persistent EBV DNA

Population-scale WGS reveals genetic determinants of persistent EBV DNA, linking immune regulation—especially antigen processing and MHC class II variation—to EBV persistence and heterogeneous disease associations.

Sherry S. Nyeo
Erin M. Cumming
Caleb A. Lareau
ResearchOpen Access28 Jan 2026
Nature

P: 1-9
Epstein-Barr virus hijacks histone demethylase machinery to drive epithelial malignancy progression through KDM5B upregulation

Ya-Qing Zhou
Jia-Xin Jiang
Jin-Xin Bei
ResearchOpen Access10 Mar 2025
Signal Transduction and Targeted Therapy

Volume: 10, P: 1-16
1093 Transmission of Epstein-Barr Virus(EBV) by Transfusion of Blood

G R Fleisher
Research01 Apr 1985
Pediatric Research

Volume: 19, P: 293
Successful treatment of Epstein–Barr virus-induced transverse myelitis with ganciclovir and cytomegalovirus hyperimmune globulin following unrelated bone marrow transplantation

B Gruhn
A Meerbach
F Zintl
Research23 Dec 1999
Bone Marrow Transplantation

Volume: 24, P: 1355-1358
Epstein–Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation

N Milpied
M Coste-Burel
J-L Harousseau
Research05 Mar 1999
Bone Marrow Transplantation

Volume: 23, P: 629-630
Mountain gorilla lymphocryptovirus has Epstein-Barr virus-like epidemiology and pathology in infants

Tierra Smiley Evans
Linda J. Lowenstine
Christine Kreuder Johnson
ResearchOpen Access13 Jul 2017
Scientific Reports

Volume: 7, P: 1-11
Epstein–Barr virus and Hodgkin’s disease: further evidence for the three disease hypothesis

AA Armstrong
FE Alexander
RF Jarrett
Research12 Aug 1998
Leukemia

Volume: 12, P: 1272-1276
Risk factors for Hodgkin’s disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents

F E Alexander
R F Jarrett
R A Cartwright
ResearchOpen Access03 Feb 2000
British Journal of Cancer

Volume: 82, P: 1117-1121
Epstein–Barr virus peptides derived from latent cycle proteins alter NKG2A + NK cell effector function

Berenice Mbiribindi
Josselyn K. Pena
Sheri M. Krams
ResearchOpen Access17 Nov 2020
Scientific Reports

Volume: 10, P: 1-13
The influence of human genetic variation on Epstein–Barr virus sequence diversity

Sina Rüeger
Christian Hammer
Sabine Yerly
ResearchOpen Access25 Feb 2021
Scientific Reports

Volume: 11, P: 1-12
Is there a chronometer hidden deep in the Sun?

R. H. Dicke
Research14 Dec 1978
Nature

Volume: 276, P: 676-680
Deuteron Quadrupole Coupling and Hydrogen Bonding in Crystals

R. BLINC
D. HADŽI
Research17 Dec 1966
Nature

Volume: 212, P: 1307-1309
TCR–like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus–transformed B lymphoblastoid cells expressing different HLA-A*02 microvariants

Junyun Lai
Joanna Ai Ling Choo
Paul A. MacAry
ResearchOpen Access30 Aug 2017
Scientific Reports

Volume: 7, P: 1-11
Epstein–Barr virus serology and gastric cancer incidence and survival

J Koshiol
Y-L Qiao
P R Taylor
ResearchOpen Access06 Nov 2007
British Journal of Cancer

Volume: 97, P: 1567-1569
The interaction of Multiple Sclerosis risk loci with Epstein-Barr virus phenotypes implicates the virus in pathogenesis

Ali Afrasiabi
Grant P. Parnell
David R. Booth
ResearchOpen Access13 Jan 2020
Scientific Reports

Volume: 10, P: 1-11
Natural Inhibitor of the Gypsy Moth Sex Attractant

R. T. CARDÉ
W. L. ROELOFS
C. C. DOANE
Research16 Feb 1973
Nature

Volume: 241, P: 474-475
Epstein–Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship

L. Jeffrey Medeiros
Mario L. Marques-Piubelli
Roberto N. Miranda
Research05 Jul 2021
Modern Pathology

Volume: 34, P: 2154-2167
Solar luminosity and the sunspot cycle

R. H. Dicke
Research05 Jul 1979
Nature

Volume: 280, P: 24-27
MYC directly transactivates CR2/CD21, the receptor of the Epstein–Barr virus, enhancing the viral infection of Burkitt lymphoma cells

Ester Molina
Lucía García-Gutiérrez
Javier León
Research29 Sept 2023
Oncogene

Volume: 42, P: 3358-3370
Epstein-Barr virus latent membrane protein does not inhibit differentiation and induces tumorigenicity of human epithelial cells

L J Nicholson
P Hopwood
D H Crawford
Research17 Jul 1997
Oncogene

Volume: 15, P: 275-283
An unexpectedly high incidence of Epstein–Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastoma

J L Powell
N J Bunin
S A Grupp
Research19 Jan 2004
Bone Marrow Transplantation

Volume: 33, P: 651-657
The Epstein-Barr virus encoded LMP1 oncoprotein modulates cell adhesion via regulation of activin A/TGFβ and β1 integrin signalling

Mhairi A. Morris
Christopher W. Dawson
Lawrence S. Young
ResearchOpen Access19 Jan 2016
Scientific Reports

Volume: 6, P: 1-13
Epstein−Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas

Eleni Anastasiadou
Dina Stroopinsky
Frank J Slack
ResearchOpen Access26 Jun 2018
Leukemia

Volume: 33, P: 132-147
Successful treatment of natural killer (NK) cell leukemia following a long-standing chronic active Epstein–Barr virus (CAEBV) infection with allogeneic bone marrow transplantation

Y Ebihara
A Manabe
K Tsuji
Research10 Jun 2003
Bone Marrow Transplantation

Volume: 31, P: 1169-1171
Chronic active Epstein–Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantation

T Taketani
A Kikuchi
K Yamamoto
Research11 Apr 2002
Bone Marrow Transplantation

Volume: 29, P: 531-533
Erratum: The microenvironment of classical Hodgkin lymphoma: heterogeneity by Epstein-Barr virus presence and location within the tumor

R Wu
A Sattarzadeh
L Visser
Amendments and Corrections26 Jan 2018
Blood Cancer Journal

Volume: 8, P: e622
Structure and immunogenicity of an engineered soluble prefusion-stabilized EBV gB antigen

Epstein–Barr virus (EBV) is a widespread herpesvirus linked to cancer and autoimmune disease. The authors in this work design and characterize a stabilized prefusion form of gB, an essential viral fusion protein, advancing EBV vaccine and therapeutic development.

Ryan S. McCool
Cory M. Acreman
Jason S. McLellan
ResearchOpen Access03 Jan 2026
Nature Communications

Volume: 17, P: 1-13
Establishment of a monkey kidney epithelial cell line with the BARF1 open reading frame from Epstein-Barr Virus

Ming Xin Wei
Mireille de Turenne-Tessier
Tadamasa Ooka
Research26 Jun 1997
Oncogene

Volume: 14, P: 3073-3081
South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's disease

K J Flavell
J P Biddulph
P G Murray
ResearchOpen Access31 Jul 2001
British Journal of Cancer

Volume: 85, P: 350-356
Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas

F Fina
S Romain
P M Martin
ResearchOpen Access20 Mar 2001
British Journal of Cancer

Volume: 84, P: 783-790
Assessment and characterization of the cytolytic T lymphocyte response against Epstein–Barr virus in patients with non-Hodgkin’s lymphoma after autologous peripheral blood stem cell transplantation

A Nolte
R Buhmann
M Hallek
Research23 Apr 1998
Bone Marrow Transplantation

Volume: 21, P: 909-916
Cytomegalovirus, Epstein–Barr virus and risk of breast cancer before age 40 years: a case–control study

A K Richardson
B Cox
J L Hopper
ResearchOpen Access20 Apr 2004
British Journal of Cancer

Volume: 90, P: 2149-2152
The nitroreductase/CB1954 combination in Epstein-Barr virus-positive B-cell lines: Induction of bystander killing in vitro and in vivo

Eva-Maria Westphal
Jiqian Ge
Shannon C Kenney
Research18 May 2000
Cancer Gene Therapy

Volume: 7, P: 97-106
Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab

I García-Cadenas
N Castillo
J Sierra
Research12 Jan 2015
Bone Marrow Transplantation

Volume: 50, P: 579-584
Effect of material deprivation on Epstein–Barr virus infection in Hodgkin’s disease in the West Midlands

K Flavell
C Constandinou
P Murray
ResearchOpen Access09 Apr 1999
British Journal of Cancer

Volume: 80, P: 604-608
A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein–Barr virus in adults with human immunodeficiency virus-1

R Newton
L Carpenter
C Boshoff
ResearchOpen Access16 May 2006
British Journal of Cancer

Volume: 94, P: 1504-1509

Previous page
page 1
page 2
page 3
…
page 46
Next page

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

© 2026 Springer Nature Limited